Neuropilin-1 and Chemoresistance in Pancreatic Cancer
Author Information
Author(s): Wey J S, Gray M J, Fan F, Belcheva A, McCarty M F, Stoeltzing O, Somcio R, Liu W, Evans D B, Klagsbrun M, Gallick G E, Ellis L M
Primary Institution: The University of Texas MD Anderson Cancer Center
Hypothesis
NRP-1 expression by pancreatic cancer cells contributes to the malignant phenotype.
Conclusion
Overexpression of NRP-1 in pancreatic cancer cells increases resistance to chemotherapy and anoikis.
Supporting Evidence
- NRP-1 overexpression increased MAPK signaling.
- Cells with high NRP-1 levels showed greater resistance to gemcitabine and 5-FU.
- Downregulation of NRP-1 increased chemosensitivity in Panc-1 cells.
Takeaway
This study found that a protein called NRP-1 helps pancreatic cancer cells survive better against treatments and when they lose their attachment to other cells.
Methodology
NRP-1 was overexpressed in pancreatic cancer cell lines, and effects on signaling, anoikis, and chemosensitivity were assessed using various assays.
Limitations
The study was conducted in vitro, and results may not directly translate to clinical outcomes.
Statistical Information
P-Value
p<0.03
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website